Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First Three Quarters of 2025 SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- On October 28, 2025, Shanghai Fosun Pharmaceutical (Group)...
MMTEC, Inc. Announces Receipt of Nasdaq Delisting Determination Regarding Minimum Bid Price Deficiency
HONG KONG, Oct. 28, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on October 27, 2025, the Company...
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies Partnership with T cell experts...
China Yuchai Announces Board Change
SINGAPORE, Oct. 28, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") announced today that Mr. Wu Qiwei has resigned as a Director of the Company with effect from October 27, 2025. Mr. Wu has also...
New Oriental Announces Results for the First Fiscal Quarter Ended August 31, 2025
BEIJING, Oct. 28, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results...
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage occurred. Data suggest that LT3001 has the potential to provide significant clinical...
Ingenico Announces Leadership Transition Plan and Appoints Coffs Harbour Local Floris de Kort as Chief Executive Officer
PARIS and SYDNEY, Oct. 28, 2025 /PRNewswire/ -- Ingenico, the global leader in payments acceptance solutions, today announced the appointment of Floris de Kort as Chief Executive Officer, effective November 1st, 2025, to lead Ingenico's next phase...
P&W Solutions Receives Frost & Sullivan's 2025 Japan Competitive Strategy Leadership Recognition in Workforce Management Solutions
The company demonstrates innovation and customer-centric excellence through dynamic resource management and localized workforce engagement solutions. SAN ANTONIO, Oct. 28, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that P&W...
615 HUME FREEWAY PTY LTD ANNOUNCES OFFERING OF AUD 9,455,635 MEZZANINE SECURED LOAN NOTE OFFER
MELBOURNE, Australia, Oct. 28, 2025 /PRNewswire/ -- 615 Hume Freeway Pty Ltd ACN 654 004 298 (the Issuer) is seeking to raise a total of AUD 9,455,635 in funds by the issue of loan notes, according to an announcement today by the underwriter Banner...
Standard Foods Announces Strategic Partnership and Investment in Hello Health to Strengthen the Bridge Between Digital Health and Nutrition in Southeast Asia.
SINGAPORE, Oct. 28, 2025 /PRNewswire/ -- Hello Health Group (HHG), Asia's leading digital health and wellness platform, and Standard Foods Group (SFG), a leading nutrition and health-related consumer goods company headquartered in Taiwan, are...